Hanmi does not infringe AstraZeneca's Nexium: U.S.court

WASHINGTON (Reuters) - The drug company AstraZeneca PLC lost a bid on Thursday to defend its widely used heartburn drug Nexium when an appeals court ruled that a new drug from Hanmi Pharmaceuticals did not infringe on Nexium patents.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news